UniProt P24295
P24295
P24295 (UniProt P24295): 8 experimental structures and 1 predicted model on GenesisL1. Binding sites, druggability and experiment against prediction (TM-score) in GL1X.
- UniProt
- P24295
- Experimental structures
- 8
- Predicted models
- 1
Structures
9 records of P24295 in the MolNFT archive: 8 experimental, 1 predicted.
| Entry | Title | Method | Chains | Ligands | Pockets |
|---|---|---|---|---|---|
| 1AUP | Glutamate dehydrogenase | x-ray diffraction | A | — | — |
| 1AUP | Glutamate dehydrogenase | x-ray diffraction | A | — | — |
| 1BGV | Glutamate dehydrogenase | x-ray diffraction | A | — | — |
| 1BGV | Glutamate dehydrogenase | x-ray diffraction | A | — | — |
| 1HRD | Glutamate dehydrogenase | x-ray diffraction | A, B, C | — | — |
| 1HRD | Glutamate dehydrogenase | x-ray diffraction | A, B, C | — | — |
| 1K89 | K89L mutant of glutamate dehydrogenase | x-ray diffraction | A | — | — |
| 1K89 | K89L mutant of glutamate dehydrogenase | x-ray diffraction | A | — | — |
| P24295 | AlphaFold monomer V2.0 prediction for NAD-specific glutamate dehydrogenase (P24295) | predicted | A | — | — |
Experiment against prediction
- 1K89 chain A against the predicted model P24295: TM-score 1.00, RMSD 0.26 Å
- 1K89 chain A against the predicted model P24295: TM-score 1.00, RMSD 0.26 Å
- 1BGV chain A against the predicted model P24295: TM-score 1.00, RMSD 0.28 Å
- 1BGV chain A against the predicted model P24295: TM-score 1.00, RMSD 0.28 Å
- 1AUP chain A against the predicted model P24295: TM-score 0.98, RMSD 1.18 Å
- 1AUP chain A against the predicted model P24295: TM-score 0.98, RMSD 1.18 Å
- 1HRD chain B against the predicted model P24295: TM-score 0.95, RMSD 1.82 Å
- 1HRD chain B against the predicted model P24295: TM-score 0.95, RMSD 1.82 Å
- 1HRD chain A against the predicted model P24295: TM-score 0.93, RMSD 2.21 Å
- 1HRD chain A against the predicted model P24295: TM-score 0.93, RMSD 2.21 Å
Elsewhere
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.